UniQure plunges as Huntington's trial data disappoints investors - reuters.com
UniQure plunges as Huntington's trial data disappoints investors reuters.com
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxNdk54TXFOY1lDS0kwWmtDODhMemZCenExUWtWTXFPNkx0b0ZsQXREaWNBcm1OeWNITG1aSTY3OW9IeWd4M1RKSFhrUmNPSWhpTnROZ3JjMVdPUWg4QXhPemRIdncwNnFVb3YzNUVsbUtNZmVxN1owV0FFMndRUldiZjBEdlJoWkpTZk1SbVQ2c3B6bF9MYWdqeVNMU0ktTTN3MUVGem9HakEzdGptdlh3RThrdGVoMFY2aXJWZG1nbnpDV2VWZlB0RndxcTUxdnQ2Mm9IS2JhdFJXUkhibmlvZ2d5b0d4UQ?oc=5" target="_blank">UniQure plunges as Huntington's trial data disappoints investors</a> <font color="#6f6f6f">reuters.com</font>
Similar Stories
Related coverage based on topic and tags
Oura joins wave of IPO delays as markets turn shaky - Reuters
Oura joins wave of IPO delays as markets turn shaky Reuters
September 29, 2026 at 11:35 AMOura delays US IPO as fall market jitters deepen - reuters.com
Oura delays US IPO as fall market jitters deepen reuters.com
September 29, 2026 at 11:29 AMBioNTech to shutter three sites in Germany as no buyers emerge - Reuters
BioNTech to shutter three sites in Germany as no buyers emerge Reuters
September 28, 2026 at 08:00 PMUS FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMAI infra firm Accelevation's shares fall in tepid Nasdaq debut - reuters.com
AI infra firm Accelevation's shares fall in tepid Nasdaq debut reuters.com
September 30, 2026 at 06:14 PMExperimental Lilly combination drug tops Zepbound in weight-loss trial - Reuters
Experimental Lilly combination drug tops Zepbound in weight-loss trial Reuters
September 30, 2026 at 05:34 PM